ZF-pharma has developed patented technology for the automated in vivo high-throughput screening of pharmaceutical drug candidates against diseases.
This is achieved through novel robotic screens using model systems such as zebrafish. We seek industrial partners that are interested in obtaining a license for this technology or, alternatively, would prefer to outsource screening of TB drugs to ZF-pharma.

For those whom are interested:
The screening system is described in the peer reviewed journal PloS ONE here.
The patent is published on Espacenet here.
For a brief overview of the system please view our flyer here.
Pharmaceutical products
The mission of ZF-pharma is to develop products for pharmaceutical applications based on fish embryo screening systems.

Among our products are patented high throughput screening systems for infectious disease.
Technology
  • High throughput injection and drug treatment system in fish eggs and embryos for infectious disease screening


  • Marker and drug target discovery for disease progression based on deep sequencing of the transcriptome and high throughput screening
Latest News
22-3-2011
ZF-pharma starts collaboration with GSK for tuberculosis screening

16-2-2011
Robot Injection system described in PloS ONE

15-2-2011
Tuberculosis screening receives media attention from SenterNovem
(in Dutch)

Last update April 4th 2011